TipRanks
Endonovo Therapeutics (ENDV)
OTHER OTC:ENDV
US Market
ENDV
Endonovo Therapeutics
RESEARCH TOOLSreports
Want to see ENDV full AI Analyst Report?

Endonovo Therapeutics (ENDV) Income Statement

24 Followers

Endonovo Therapeutics Income Statement

Last quarter (Q2 2026), Endonovo Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Endonovo Therapeutics's net income was $-588.37K. See Endonovo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 0.00$ 10.04K$ 140.24K$ 135.35K$ 73.11K
Gross Profit
$ 0.00$ -615.20K$ -514.51K$ 125.36K$ 58.12K
Operating Expenses
$ 945.77K$ 944.74K$ 2.40M$ 3.39M$ 2.28M
Depreciation and Amortization
$ 0.00$ 618.53K$ 646.91K$ 646.91K$ 648.49K
EBITDA
$ -945.77K$ -941.40K$ 8.85M$ -16.51M$ -1.51M
Operating Income
$ -945.77K$ -1.56M$ -2.92M$ -3.26M$ -2.23M
Other Income/Expenses
$ -1.23M$ -1.24M$ 9.84M$ -15.21M$ -878.35K
Pretax Income
$ -2.18M$ -2.80M$ 6.92M$ -18.47M$ -3.10M
Net Income
$ -2.18M$ -2.80M$ 6.92M$ -18.47M$ -3.10M
Per Share Metrics
Basic EPS
$ >-0.01$ >-0.01$ 0.03$ -0.13$ -0.05
Diluted EPS
$ >-0.01$ >-0.01$ <0.01$ -0.13$ -0.05
Weighted Average Shares Outstanding
 1.10B 543.87M 276.36M 139.21M 59.84M
Weighted Average Shares Outstanding (Diluted)
 1.81B 543.87M 1.35B 139.21M 59.84M
Currency in USD

Endonovo Therapeutics Earnings and Revenue History